Related Experiment Video
Updated: May 12, 2025

Automated Imaging and Analysis for the Quantification of Fluorescently Labeled Macropinosomes
Published on: August 24, 2021
LincNEAT1 Encoded-NEAT1-31 Promotes Phagocytosis by Directly Activating the Aurora-A-PI3K-AKT Pathway.
Jie Li1,2, Jing Zhang1,2, Xixi Li3
1Department of thyroid and breast surgery, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, 510623, P.R. China.
Researchers identified a new micropeptide, NEAT1-31, that enhances macrophage phagocytosis. This discovery offers a promising new therapeutic strategy for improving cancer immunotherapy by boosting immune cell activity.
Area of Science:
- Immunology
- Molecular Biology
- Cancer Research
Background:
- Macrophages are crucial immune cells mediating phagocytosis and antigen presentation.
- Long non-coding RNA nuclear enriched abundant transcript 1 (LincNEAT1) is involved in phagocytosis, but its activators remain unclear.
- Understanding phagocytic activators is key to advancing immunotherapy.
Purpose of the Study:
- To identify intrinsic phagocytic activators within the immune system.
- To explore the role of LincNEAT1 and its derivatives in macrophage phagocytosis.
- To evaluate the therapeutic potential of identified activators in cancer immunotherapy.
Main Methods:
- In vitro phagocytosis assays using primary macrophages and breast cancer cells.
- Ribosome profiling to identify immune system-specific phagocytic activators.
- Phosphoproteomic analysis to elucidate molecular mechanisms.
Main Results:
- LincNEAT1 and its encoded micropeptide NEAT1-31 were significantly upregulated in phagocytic macrophages.
- NEAT1-31 directly promoted cancer cell phagocytosis and enhanced anti-CD47 efficacy in vitro and in vivo.
- NEAT1-31 was found to activate Aurora-A and the PI3K/Akt signaling pathway.
Conclusions:
- NEAT1-31 is a novel protein drug that directly enhances macrophage phagocytic function.
- This finding provides a new therapeutic avenue for cancer immunotherapy.
- Targeting NEAT1-31 could improve treatment outcomes for various cancers.
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
Delivery Pathways to the Lysosome
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
Phagocytosis of Apoptotic Cells
Normal cells contain receptors that prevent them from being recognized...
Phagocytosis
The objective of phagocytosis is often destruction. Cells use phagocytosis to eliminate unwelcome visitors, like pathogens (e.g., viruses and bacteria). Many immune system cells,...
Immune Surveillance by NK Cells and Phagocytes
Natural Killer Cells: The Fast Responders
NK cells are large granular lymphocytes found in the blood and lymphatic system. These...
Intracellular Signaling Affects Focal Adhesions
Some...

